The Enterprise Value as of December 2025 (TTM) for Orchestra BioMed Holdings, Inc. (OBIO) is 247.47M

According to Orchestra BioMed Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 247.47M. This represents a change of 75.52% compared to the average of 141.00M of the last 4 quarters.

Orchestra BioMed Holdings, Inc. (OBIO) Historical Enterprise Value (quarterly & annually)

How has OBIO Enterprise Value performed in the past?

The mean historical Enterprise Value of Orchestra BioMed Holdings, Inc. over the last ten years is 202.13M. The current 247.47M Enterprise Value has changed 12.14% with respect to the historical average. Over the past ten years (40 quarters), OBIO's Enterprise Value was at its highest in in the March 2023 quarter at 534.03M. The Enterprise Value was at its lowest in in the June 2025 quarter at 86.11M.

Orchestra BioMed Holdings, Inc. (OBIO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Orchestra BioMed Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Orchestra BioMed Holdings, Inc. (OBIO) Average Enterprise Value

How has OBIO Enterprise Value performed in the past?

The current Enterprise Value of Orchestra BioMed Holdings, Inc. (OBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Orchestra BioMed Holdings, Inc. (OBIO) Enterprise Value vs. Peers

How is OBIO’s Enterprise Value compared to its peers?

Orchestra BioMed Holdings, Inc.’s Enterprise Value is greater than Prelude Therapeutics Incorporated (53.80M), less than Inventiva S.A. (419.54M), greater than Caribou Biosciences, Inc. (194.64M), less than Enanta Pharmaceuticals, Inc. (469.35M), greater than Invivyd, Inc. (212.37M), less than Pyxis Oncology, Inc. (279.07M), greater than Protara Therapeutics, Inc. (237.55M), greater than Tenaya Therapeutics, Inc. (184.99M), greater than Eupraxia Pharmaceuticals Inc. (188.00M), greater than Avalo Therapeutics, Inc. (175.77M),

Build a custom stock screener for Orchestra BioMed Holdings, Inc. (OBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orchestra BioMed Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Orchestra BioMed Holdings, Inc. (OBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Orchestra BioMed Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.